Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding.
about
The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminaseStructure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivA step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cellsStructure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1Fluorogenic probes for monitoring peptide binding to class II MHC proteins in living cellsCrystal Structure of the HLA-DM–HLA-DR1 Complex Defines Mechanisms for Rapid Peptide SelectionIMPIPS: the immune protection-inducing protein structure concept in the search for steric-electron and topochemical principles for complete fully-protective chemically synthesised vaccine developmentRubella virus-specific cytotoxic T-lymphocyte responses: identification of the capsid as a target of major histocompatibility complex class I-restricted lysis and definition of two epitopes.Identification of a motif for HLA-DR1 binding peptides using M13 display librariesHLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptideHuman CD4+ T cell epitopes from vaccinia virus induced by vaccination or infectionRous-Whipple Award Lecture. Chemical features of peptide selection by the class II histocompatibility molecules.Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides.Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) regionHLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes.The nonconventional MHC class II molecule DM governs diabetes susceptibility in NOD miceHigh-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinationsBinding of a soluble alpha beta T-cell receptor to superantigen/major histocompatibility complex ligandsThe Thermodynamic Mechanism of Peptide-MHC Class II Complex Formation Is a Determinant of Susceptibility to HLA-DM.Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritisExpression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH.Antibody recognition of an immunogenic influenza hemagglutinin-human leukocyte antigen class II complex.A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis.Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex.Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseasesConformational variants of class II MHC/peptide complexes induced by N- and C-terminal extensions of minimal peptide epitopes.Quantitative analysis of peptides from myelin basic protein binding to the MHC class II protein, I-Au, which confers susceptibility to experimental allergic encephalomyelitis.Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705.An immunodominant Kb-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes.Interaction of pigeon cytochrome c-(43-58) peptide analogs with either T cell antigen receptor or I-Ab molecule.Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutininSuperactivation of an immune response triggered by oligomerized T cell epitopes.Solution binding of an antigenic peptide to a major histocompatibility complex class I molecule and the role of beta 2-microglobulin.Interaction of the pertussis toxin peptide containing residues 30-42 with DR1 and the T-cell receptors of 12 human T-cell clones.Thermodynamics of Peptide-MHC Class II Interactions: Not all Complexes are Created Equal.Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR.Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris.A deimmunised form of the ribotoxin, α-sarcin, lacking CD4+ T cell epitopes and its use as an immunotoxin warhead.Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.
P2860
Q24671041-A3599452-666D-45DD-95A0-70DC128554DFQ24673986-D95C0B3C-9CB7-4836-8B12-D173E8E15145Q26747063-A41873B6-E00F-4408-B364-B5B70EB0C07AQ27627794-6D15FC94-C5B6-455D-9773-F85EFA9232B9Q27644030-2B4B6C7A-2989-450C-BE87-2C7E7C14386AQ27675568-F1567D4E-AE08-4F64-A1BB-0654FDCB4AE9Q30373743-2EA2E4F4-8942-409F-8D96-B04D366A28ECQ30452149-865402F8-DB84-4087-8FC0-A911092AFAF8Q33191162-DBAE6B41-6E37-4C94-B9D9-982DE0EB2DBDQ33292091-44F0E46C-2ABD-48D2-8FE9-3FB6E9D25EE2Q33302672-DD17F9C1-41B8-44DB-B202-5F8ECBF72507Q33541540-B580E265-BD0B-40D4-8056-E82CABCD13E7Q33575103-B6D477A5-1114-44C4-B371-3F6E4F25804EQ33887531-94B4D5B6-2A40-4524-ABF9-A0C88917494AQ34483195-CA40D754-8C7C-4604-AD3C-4951C64A4BADQ34590244-4042B036-5933-4427-ACDE-B81456F07488Q35235094-E3F26DE1-C1F6-46D7-952B-3F4D1F18DFCCQ35715122-06590F1C-FD51-4660-ACB5-F508FC53A7EEQ35861946-7DC723AE-16F0-405E-BFAF-61AF407D8CDBQ36138254-F1F6B2F3-E828-4A43-A607-3DC3749B0B2EQ36230148-37072557-B350-4C10-B474-4A12319F0955Q36230192-D3A5AC8C-0259-4480-BA25-B5B3730CC6AFQ36231694-901A5698-06FB-4973-9CA6-87DBF23ECA6CQ36232156-6A481A4C-86AA-4D5E-AC81-A32E64D22E6AQ36361966-28C4511A-DD0C-4B52-BC27-C73D359193EEQ36364807-61A45B60-EB60-4763-8777-8AD44B19B1BDQ36396787-D2554173-04F1-4752-AFB3-B1E59B68FD47Q36437858-A8CEAAD2-6DB0-4C56-A5F4-99CBA0B902D1Q36507341-CC2039E3-F85F-470C-A3D2-4A39E6B938B6Q36626812-B65CF0A9-AC87-478A-8CC2-925D361E5756Q36635102-2A990054-3656-49BC-A889-B598E5DC2D49Q36798170-80B754C0-A77A-4284-ACE3-CB0F02B48CCDQ36828919-AAC30EBD-4C79-4CF3-9A3A-FA09F6A4D071Q36890441-FDBE9AD5-A583-471E-B12C-99E2836CDA1DQ36932144-D9D2E81E-D067-430F-98CB-E73FCA617F1CQ37208000-3C601200-B097-47C6-81DF-6F9DED1C50B4Q37323197-876D17EB-A07F-4532-83A3-E294FD1F512EQ37362267-F6B29F5F-7C5F-4CA3-B600-339F14D1ED82Q37367958-B7E27FE2-FEB2-4D2A-B355-6F47F799508AQ37494529-3F1FC7D1-457D-4563-A1A2-250FBB73087C
P2860
Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Peptide binding to HLA-DR1: a ...... o alanine retains MHC binding.
@ast
Peptide binding to HLA-DR1: a ...... o alanine retains MHC binding.
@en
type
label
Peptide binding to HLA-DR1: a ...... o alanine retains MHC binding.
@ast
Peptide binding to HLA-DR1: a ...... o alanine retains MHC binding.
@en
prefLabel
Peptide binding to HLA-DR1: a ...... o alanine retains MHC binding.
@ast
Peptide binding to HLA-DR1: a ...... o alanine retains MHC binding.
@en
P2093
P2860
P1433
P1476
Peptide binding to HLA-DR1: a ...... o alanine retains MHC binding.
@en
P2093
P2860
P304
P407
P577
1990-06-01T00:00:00Z